American drugmaker Pfizer is close to a deal to purchase Global Blood Therapeutics, which manufactures a recently approved drug against sickle-cell anemia, for $5 billion, the Wall Street Journal has reported.
Aug 7, 2022
0
4
Incidence of myocarditis, pericarditis or myopericarditis is two- to threefold higher after a second dose of the Moderna Spikevax COVID-19 vaccine when compared to the Pfizer BioNTech COVID-19 vaccine; however, overall cases ...
Nov 7, 2022
0
31
On the first day of the UK campaign for COVID-19 vaccination, there were reports of two cases of anaphylaxis—a severe, potentially life-threatening allergic reaction—within minutes of administration of the Pfizer/BioNTech ...
Apr 7, 2021
0
6
COVID vaccines offered varying degrees of protection in the six months after patients receive them, with levels climbing and plunging in two cases and climbing and climbing in another, according to new UC San Francisco research ...
May 9, 2023
0
51
(AP) -- The Food and Drug Administration has approved a new Pfizer drug for patients with advanced kidney cancer that has spread to other parts of the body despite treatment with at least one previous drug.
Jan 27, 2012
0
0
The omicron variant is offering more hints about what it may have in store as it spreads around the globe: A highly transmissible virus that may cause less severe disease, and one that can be slowed—but not stopped—by ...
Dec 14, 2021
0
28
New research being presented at this year's European Congress on Obesity (ECO) in Maastricht, Netherlands (4-7 May), suggests that adults (aged 18 or older) with severe obesity generate a significantly weaker immune response ...
May 6, 2022
0
4
People who received Johnson & Johnson's COVID-19 vaccine may benefit from a booster dose of Pfizer or Moderna, preliminary results of a US study published Wednesday showed.
Oct 14, 2021
0
29
Pfizer reported Tuesday a loss following a sharp fall in the sales of its COVID-19 vaccine and therapeutic from pandemic peaks.
Oct 31, 2023
0
1
US drugs giant Pfizer will exit its consumer healthcare joint venture with GlaxoSmithKline after the unit is spun off next month, the British drugmaker said Wednesday.
Jun 1, 2022
0
1
